Cosmo Pharmaceuticals S.p.A Stock Swiss Exchange
Stocks
IT0004167463
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 08-28 | Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation | RE |
| 08-14 | Cosmo Pharmaceuticals to Adopt New Ticker on SIX Swiss Exchange | MT |
| Market Cap | 1.02B 1.18B 954M 871M 1.64B 112B 1.65B 11.31B 4.4B 56.94B 4.43B 4.33B 189B | P/E 2026 * |
879x | P/E 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise Value | 988M 1.15B 927M 846M 1.59B 109B 1.6B 10.99B 4.28B 55.34B 4.31B 4.21B 183B | EV / Sales 2026 * |
9.29x | EV / Sales 2027 * | 5.61x |
| Free-Float |
40.52% | Yield 2026 * |
3.6% | Yield 2027 * | 3.82% |
Last Transcript : Cosmo Pharmaceuticals S.p.A
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 24/05/2024 | |
| Director of Finance/CFO | - | 11/11/2024 | |
Paolo Lanzarotti
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Mauro Ajani
CHM | Chairman | 71 | 01/01/2014 |
| Director/Board Member | 71 | 01/04/2012 | |
Niall Donnelly
BRD | Director/Board Member | 54 | 24/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.52% | -7.23% | +57.90% | +108.72% | 1,031B | |
| -0.82% | -2.63% | +50.05% | +64.43% | 641B | |
| +0.37% | -3.06% | +21.87% | +74.48% | 453B | |
| -1.79% | -6.29% | +33.40% | +33.35% | 349B | |
| +4.57% | +1.58% | +26.81% | +44.17% | 290B | |
| -0.63% | -1.73% | +0.42% | +11.61% | 252B | |
| -0.59% | -3.15% | +49.83% | +67.70% | 232B | |
| +0.03% | -2.19% | -19.83% | -54.05% | 201B | |
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | |
| Average | +0.38% | -2.98% | +27.81% | +49.08% | 403.31B | |
| Weighted average by Cap. | +0.44% | -3.97% | +36.97% | +65.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 106M 123M 99.81M 91.11M 171M 11.75B 172M 1.18B 460M 5.96B 464M 453M 19.72B | 176M 204M 165M 151M 283M 19.45B 285M 1.96B 762M 9.86B 768M 751M 32.66B |
| Net income | 1.27M 1.48M 1.2M 1.09M 2.05M 141M 2.07M 14.18M 5.52M 71.43M 5.56M 5.44M 237M | 49.6M 57.61M 46.57M 42.51M 79.87M 5.48B 80.44M 552M 215M 2.78B 216M 212M 9.2B |
| Net Debt | -28.5M -33.1M -26.76M -24.43M -45.89M -3.15B -46.22M -317M -123M -1.6B -124M -122M -5.29B | -28.81M -33.46M -27.05M -24.69M -46.38M -3.18B -46.71M -320M -125M -1.61B -126M -123M -5.34B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
